Tartilla / Shutterstock.com
29 May 2019Biotechnology
BGI takes Illumina to court over patent infringement in US
Already registered?
Login to your account
If you don't have a login or your access has expired, you will need to purchase a subscription to gain access to this article, including all our online content.
For more information on individual annual subscriptions for full paid access and corporate subscription options please contact us.
To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.
For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk
Americas
2 January 2019 Ariosa Diagnostics, a subsidiary of Swiss healthcare firm Roche, has won a patent dispute with American biotechnology firm Illumina.
Americas
2 July 2019 Genetic sequencing company Illumina has continued its campaign of filing patent lawsuits against rival BGI, with the filing of three additional infringement suits.
Big Pharma
4 October 2019 A US subsidiary of Chinese genome sequencing company BGI has filed a patent infringement counterclaim against Illumina.
Editor's picks
Editor's picks
Americas
2 January 2019 Ariosa Diagnostics, a subsidiary of Swiss healthcare firm Roche, has won a patent dispute with American biotechnology firm Illumina.
Americas
2 July 2019 Genetic sequencing company Illumina has continued its campaign of filing patent lawsuits against rival BGI, with the filing of three additional infringement suits.
Big Pharma
4 October 2019 A US subsidiary of Chinese genome sequencing company BGI has filed a patent infringement counterclaim against Illumina.
Americas
2 January 2019 Ariosa Diagnostics, a subsidiary of Swiss healthcare firm Roche, has won a patent dispute with American biotechnology firm Illumina.
Americas
2 July 2019 Genetic sequencing company Illumina has continued its campaign of filing patent lawsuits against rival BGI, with the filing of three additional infringement suits.
Big Pharma
4 October 2019 A US subsidiary of Chinese genome sequencing company BGI has filed a patent infringement counterclaim against Illumina.